RU2019105691A - Биомаркеры для прогнозирования преждевременных родов из-за преждевременного разрыва плодной оболочки при недоношенной беременности и идиопатических самопроизвольных родов - Google Patents
Биомаркеры для прогнозирования преждевременных родов из-за преждевременного разрыва плодной оболочки при недоношенной беременности и идиопатических самопроизвольных родов Download PDFInfo
- Publication number
- RU2019105691A RU2019105691A RU2019105691A RU2019105691A RU2019105691A RU 2019105691 A RU2019105691 A RU 2019105691A RU 2019105691 A RU2019105691 A RU 2019105691A RU 2019105691 A RU2019105691 A RU 2019105691A RU 2019105691 A RU2019105691 A RU 2019105691A
- Authority
- RU
- Russia
- Prior art keywords
- premature
- biomarkers
- pregnant woman
- labor
- likelihood
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title claims 9
- 230000035935 pregnancy Effects 0.000 title claims 2
- 230000002269 spontaneous effect Effects 0.000 title claims 2
- 230000002028 premature Effects 0.000 title 2
- 208000006399 Premature Obstetric Labor Diseases 0.000 title 1
- 206010036600 Premature labour Diseases 0.000 title 1
- 208000026440 premature labor Diseases 0.000 title 1
- 208000005107 Premature Birth Diseases 0.000 claims 6
- 239000012472 biological sample Substances 0.000 claims 3
- 239000012528 membrane Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662371666P | 2016-08-05 | 2016-08-05 | |
| US62/371,666 | 2016-08-05 | ||
| US201762449862P | 2017-01-24 | 2017-01-24 | |
| US62/449,862 | 2017-01-24 | ||
| PCT/US2017/045576 WO2018027171A1 (en) | 2016-08-05 | 2017-08-04 | Biomarkers for predicting preterm birth due to preterm premature rupture of membranes versus idiopathic spontaneous labor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2019105691A true RU2019105691A (ru) | 2020-09-08 |
Family
ID=61073085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019105691A RU2019105691A (ru) | 2016-08-05 | 2017-08-04 | Биомаркеры для прогнозирования преждевременных родов из-за преждевременного разрыва плодной оболочки при недоношенной беременности и идиопатических самопроизвольных родов |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20180172698A1 (https=) |
| EP (1) | EP3494233A4 (https=) |
| JP (2) | JP2019532261A (https=) |
| KR (1) | KR20190046825A (https=) |
| CN (1) | CN110191963A (https=) |
| AU (1) | AU2017307584A1 (https=) |
| CA (1) | CA3032754A1 (https=) |
| IL (1) | IL264576A (https=) |
| RU (1) | RU2019105691A (https=) |
| WO (1) | WO2018027171A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10392665B2 (en) | 2015-06-19 | 2019-08-27 | Sera Prognostics, Inc. | Biomarker pairs for predicting preterm birth |
| EP4530633A3 (en) * | 2017-08-18 | 2026-03-25 | Sera Prognostics, Inc. | Pregnancy clock proteins for predicting due date and time to birth |
| US20200319197A1 (en) * | 2017-10-30 | 2020-10-08 | Carmentix Pte. Ltd. | Biomarkers of Preterm Birth |
| MX2022015727A (es) * | 2020-06-10 | 2023-03-23 | Univ Texas | Metodo para determinar riesgo de parto prematuro. |
| US12548679B2 (en) | 2020-11-05 | 2026-02-10 | Board Of Regents, The University Of Texas System | Individual optimal mode of delivery |
| CA3220282A1 (en) * | 2021-05-21 | 2022-11-24 | Sera Prognostics, Inc. | Biomarker pairs and triplets for predicting preterm birth |
| RU2763707C1 (ru) * | 2021-06-01 | 2021-12-30 | Наталья Борисовна Кузнецова | Способ прогнозирования преждевременного разрыва плодных оболочек в сроке от 22 до 28 недель беременности |
| US11664100B2 (en) | 2021-08-17 | 2023-05-30 | Birth Model, Inc. | Predicting time to vaginal delivery |
| CN118056016A (zh) * | 2021-12-08 | 2024-05-17 | 深圳华大基因股份有限公司 | 基因标志物在预测孕妇早产风险中的应用 |
| WO2024156709A1 (en) * | 2023-01-24 | 2024-08-02 | Université Clermont Auvergne | Evaluation of serum cx3cl1 for the prediction of preterm premature rupture of membranes |
| WO2024182491A1 (en) * | 2023-02-28 | 2024-09-06 | Virginia Commonwealth University | Polygenic risk estimator for cervical length change during pregnancy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050233400A1 (en) * | 2004-03-03 | 2005-10-20 | Weiner Carl P | Proteomic method for predicting success of rescue cerclage |
| RU2586412C2 (ru) * | 2012-06-09 | 2016-06-10 | Общество с ограниченной ответственностью научно-технический центр "БиоКлиникум" (ООО НТЦ "БиоКлиникум") | Способ оценки риска возникновения патологии беременности |
| US20140186332A1 (en) * | 2012-12-28 | 2014-07-03 | NX Pharmagen | Biomarkers of preterm birth |
| US20160003837A1 (en) * | 2013-01-08 | 2016-01-07 | Duke University | Biomarkers for the prediction of preterm birth |
| EP2972393A4 (en) * | 2013-03-15 | 2016-10-26 | Sera Prognostics Inc | BIOMARKERS AND METHOD FOR PREDICTING PREECLAMPSIA |
| CA2907120C (en) * | 2013-03-15 | 2023-10-17 | Sera Prognostics, Inc. | Biomarkers and methods for predicting preterm birth |
| US20140287948A1 (en) * | 2013-03-15 | 2014-09-25 | Sera Prognostics, Inc. | Biomarkers and methods for predicting preterm birth |
| US10392665B2 (en) * | 2015-06-19 | 2019-08-27 | Sera Prognostics, Inc. | Biomarker pairs for predicting preterm birth |
-
2017
- 2017-08-04 EP EP17837787.5A patent/EP3494233A4/en not_active Withdrawn
- 2017-08-04 AU AU2017307584A patent/AU2017307584A1/en not_active Abandoned
- 2017-08-04 RU RU2019105691A patent/RU2019105691A/ru not_active Application Discontinuation
- 2017-08-04 KR KR1020197006188A patent/KR20190046825A/ko not_active Withdrawn
- 2017-08-04 WO PCT/US2017/045576 patent/WO2018027171A1/en not_active Ceased
- 2017-08-04 CN CN201780062065.0A patent/CN110191963A/zh active Pending
- 2017-08-04 CA CA3032754A patent/CA3032754A1/en active Pending
- 2017-08-04 JP JP2019505476A patent/JP2019532261A/ja not_active Withdrawn
- 2017-08-04 US US15/669,746 patent/US20180172698A1/en not_active Abandoned
-
2019
- 2019-01-31 IL IL264576A patent/IL264576A/en unknown
-
2020
- 2020-08-05 US US16/986,044 patent/US20210190792A1/en not_active Abandoned
-
2022
- 2022-07-15 JP JP2022113886A patent/JP2022140511A/ja active Pending
-
2024
- 2024-06-17 US US18/745,657 patent/US20250085293A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN110191963A (zh) | 2019-08-30 |
| WO2018027171A1 (en) | 2018-02-08 |
| JP2022140511A (ja) | 2022-09-26 |
| US20180172698A1 (en) | 2018-06-21 |
| US20250085293A1 (en) | 2025-03-13 |
| EP3494233A1 (en) | 2019-06-12 |
| US20210190792A1 (en) | 2021-06-24 |
| EP3494233A4 (en) | 2020-03-18 |
| CA3032754A1 (en) | 2018-02-08 |
| AU2017307584A1 (en) | 2019-03-21 |
| IL264576A (en) | 2019-02-28 |
| JP2019532261A (ja) | 2019-11-07 |
| KR20190046825A (ko) | 2019-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2019105691A (ru) | Биомаркеры для прогнозирования преждевременных родов из-за преждевременного разрыва плодной оболочки при недоношенной беременности и идиопатических самопроизвольных родов | |
| JP2019532261A5 (https=) | ||
| Lay et al. | Reproductive factors and age at natural menopause: a systematic review and meta-analysis | |
| Schulz et al. | Maternal vitamin D sufficiency and reduced placental gene expression in angiogenic biomarkers related to comorbidities of pregnancy | |
| Hackenhaar et al. | Preterm premature rupture of the fetal membranes: association with sociodemographic factors and maternal genitourinary infections | |
| Bellos et al. | Mean platelet volume values in preeclampsia: A systematic review and meta-analysis | |
| EA201892490A1 (ru) | Пцр с мультиплексной оптимизированной амплификацией неправильно спаренных оснований (moma) в реальном времени для анализа состояния плода | |
| Herrera et al. | Cell-free DNA, inflammation, and the initiation of spontaneous term labor | |
| EA202090348A1 (ru) | Способ неинвазивного пренатального выявления аномалий половых хромосом у плода и определения пола плода в случае одноплодной и двухплодной беременности | |
| Wolfe et al. | Banking placental tissue: an optimized collection procedure for genome-wide analysis of nucleic acids | |
| Buysse et al. | Reliable noninvasive prenatal testing by massively parallel sequencing of circulating cell-free DNA from maternal plasma processed up to 24 h after venipuncture | |
| Borg et al. | Prediction of preterm birth | |
| EA201792570A1 (ru) | Мультиплексный параллельный анализ целевых геномных областей с целью неинвазивного пренатального тестирования | |
| Piotrowski et al. | Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies | |
| WO2015173430A3 (en) | Early placenta insulin-like peptide (pro-epil) | |
| MX2018010984A (es) | Deteccion del tiempo de inseminacion apropiado mediante reconocimiento del patron de marcador de preñez multiple (mpmp). | |
| Patterson et al. | Delayed-type hypersensitivity and hepatitis B vaccine responses, in vivo markers of cellular and humoral immune function, and the risk of AIDS or death | |
| Mahmoud et al. | The correlation between maternal hypomagnesemia and preterm labour | |
| Rahman et al. | Chlamydia trachomatis IgM seropositivity during pregnancy and assessment of its risk factors | |
| Pillay et al. | Why are we still measuring red cell folate instead of just serum folate? | |
| Terayama et al. | Coexpression of TrkB and PD-L1 on human placenta | |
| RU2012157453A (ru) | Способ дифференциальной диагностики цервикальных дисплазий и рака шейки матки | |
| James et al. | 8.4 Serum beta defensin concentration in the first trimester is related to genotype, and is higher in women who develop PPROM and deliver before 34 weeks | |
| Kharbanda et al. | Plasma proteome profiling identifies predictive signatures for preterm birth risk | |
| BOBE et al. | Comparative study of serum calcium and serum magnesium levels in patients of preeclampsia and normotensive patients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20200805 |